BioSpace News Archive

Company Has Collected More than 400 Tons of Unwanted Medications to Date

“SUPPORT for Patients and Communities Act” expands eligibility of Medicare Part D beneficiaries to receive Medication Therapy Management (MTM) services from pharmacists.

AmerisourceBergen released the following comment regarding the signing of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (“SUPPORT”) for Patients and Communities Act (H.R. 6) passed by the U.S. House of Representatives on Sept. 28, the U.S. Senate on Oct. 3, and signed into law today by President Trump during a ceremony at the White House.

Partnership with Walgreens has collected more than 400 tons of unused, unwanted or expired medications to date

Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that Craig Rayner, PharmD, MBA, senior vice president, integrated drug development with Certara Strategic Consulting, has been awarded the 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University

Novocure (NASDAQ: NVCR) announced today the retirement of Novocure founder Professor Yoram Palti, MD, PhD, and director Louis J. Lavigne, Jr. from the board of directors effective October 24, 2018.

Wize Pharma, Inc. (“Wize Pharma” or the “Company”) (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced the closing of its previously announced private placement resulting in gross proceeds to Wize Pharma of $4.45 million,

Chubb Limited (NYSE: CB) announced today that Joe Vasquez has been named Senior Vice President, Chubb Group and head of the company’s global accident and health insurance business.

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today the presentation of a clinical research abstract at the 37th Annual Fall Clinical Dermatology Conference in Las Vegas, Nevada.

Dr. Daniel Fabbri, Founder & CEO of Maize Analytics spoke at the U.S. Department of Health and Human Services (HHS) conference on “Data Min(d)ing: Privacy and Our Digital Identities,” a meeting featuring a slate of privacy thought leaders from academia, government, and industry.